Tokyo Tape
Sign in
← Eucalia

Annual report

286A.TEDINET S100XUVY
Period2025-01-01 → 2025-12-31
Filed2026-03-27
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 133
MetricValuePeriodScopeSource row
Revenue¥24.7bn2025-01-01 → 2025-12-31Cons.Net sales
Revenue¥19.8bn2024-01-01 → 2024-12-31Cons.Net sales
Revenue¥18.1bn2023-01-01 → 2023-12-31dCons.Net sales (5-year summary)
Revenue¥16.6bn2022-01-01 → 2022-12-31dCons.Net sales (5-year summary)
Operating income¥2.4bn2025-01-01 → 2025-12-31Cons.Operating income
Operating income¥2.3bn2024-01-01 → 2024-12-31Cons.Operating income
Ordinary income¥2.1bn2025-01-01 → 2025-12-31Cons.Ordinary income
Ordinary income¥2.8bn2024-01-01 → 2024-12-31Cons.Ordinary income
Ordinary income¥1.9bn2023-01-01 → 2023-12-31dCons.Ordinary income loss (5-year summary)
Ordinary income¥784m2022-01-01 → 2022-12-31dCons.Ordinary income loss (5-year summary)
Profit before tax¥3.1bn2025-01-01 → 2025-12-31Cons.Income before income taxes
Profit before tax¥3.1bn2024-01-01 → 2024-12-31Cons.Income before income taxes
Net income (owners)¥2.8bn2025-01-01 → 2025-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.0bn2024-01-01 → 2024-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.1bn2023-01-01 → 2023-12-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥980m2022-01-01 → 2022-12-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income¥2.9bn2025-01-01 → 2025-12-31Cons.Profit loss
Net income¥2.1bn2024-01-01 → 2024-12-31Cons.Profit loss
Total assets¥65.1bnat 2025-12-31Cons.Assets
Total assets¥60.1bnat 2024-12-31Cons.Assets
Total assets¥51.0bnat 2023-12-31dCons.Total assets (5-year summary)
Total assets¥42.6bnat 2022-12-31dCons.Total assets (5-year summary)
Total liabilities¥43.3bnat 2025-12-31Cons.Liabilities
Total liabilities¥41.2bnat 2024-12-31Cons.Liabilities
Net assets / equity¥21.8bnat 2025-12-31Cons.Net assets
Net assets / equity¥19.0bnat 2024-12-31Cons.Net assets
Net assets / equity¥11.8bnat 2023-12-31dCons.Net assets
Net assets / equity¥10.4bnat 2022-12-31dCons.Net assets (5-year summary)
Cash and deposits¥9.1bnat 2025-12-31Cons.Cash and deposits
Cash and deposits¥11.2bnat 2024-12-31Cons.Cash and deposits
Cash & equivalents¥9.1bnat 2025-12-31Cons.Cash and cash equivalents
Cash & equivalents¥11.1bnat 2024-12-31Cons.Cash and cash equivalents
Cash & equivalents¥6.7bnat 2023-12-31dCons.Cash and cash equivalents
Cash & equivalents¥6.1bnat 2022-12-31dCons.Cash and cash equivalents (5-year summary)
Operating cash flow−¥1.9bn2025-01-01 → 2025-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥1.3bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in operating activities
Operating cash flow−¥209m2023-01-01 → 2023-12-31dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥2.7bn2022-01-01 → 2022-12-31dCons.Net cash provided by used in operating activities (5-year summary)
Investing cash flow−¥2.3bn2025-01-01 → 2025-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥406m2024-01-01 → 2024-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥5.6bn2023-01-01 → 2023-12-31dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥1.4bn2022-01-01 → 2022-12-31dCons.Net cash provided by used in investing activities (5-year summary)
Financing cash flow¥1.8bn2025-01-01 → 2025-12-31Cons.Net cash provided by used in financing activities
Financing cash flow¥3.5bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in financing activities
Financing cash flow¥6.3bn2023-01-01 → 2023-12-31dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥5.0bn2022-01-01 → 2022-12-31dCons.Net cash provided by used in financing activities (5-year summary)
EPS (basic)¥78.072025-01-01 → 2025-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥64.42024-01-01 → 2024-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥35.182023-01-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥32.82022-01-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥76.752025-01-01 → 2025-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥63.122024-01-01 → 2024-12-31Cons.Diluted earnings per share (5-year summary)
Net assets per share¥574.26at 2025-12-31Cons.Net assets per share (5-year summary)
Net assets per share¥507.67at 2024-12-31Cons.Net assets per share (5-year summary)
Net assets per share¥362.04at 2023-12-31dCons.Net assets per share (5-year summary)
Net assets per share¥324.44at 2022-12-31dCons.Net assets per share (5-year summary)
Equity ratio31.5%at 2025-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio29.9%at 2024-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio21.3%at 2023-12-31dCons.Equity to asset ratio (5-year summary)
Equity ratio22.7%at 2022-12-31dCons.Equity to asset ratio (5-year summary)
ROE14.4%2025-01-01 → 2025-12-31Cons.Rate of return on equity (5-year summary)
ROE14.1%2024-01-01 → 2024-12-31Cons.Rate of return on equity (5-year summary)
ROE10.2%2023-01-01 → 2023-12-31dCons.Rate of return on equity (5-year summary)
ROE10.3%2022-01-01 → 2022-12-31dCons.Rate of return on equity (5-year summary)
Employees1,347at 2025-12-31Cons.Number of employees
Employees833at 2024-12-31Cons.Number of employees
Employees769at 2023-12-31dCons.Number of employees
Employees699at 2022-12-31dCons.Number of employees
Revenue¥6.2bn2025-01-01 → 2025-12-31StandaloneNet sales
Revenue¥5.6bn2024-01-01 → 2024-12-31StandaloneNet sales
Revenue¥5.4bn2023-01-01 → 2023-12-31dStandaloneNet sales (5-year summary)
Revenue¥4.0bn2022-01-01 → 2022-12-31dStandaloneNet sales (5-year summary)
Revenue¥2.9bn2021-01-01 → 2021-12-31dStandaloneNet sales (5-year summary)
Operating income¥1.4bn2025-01-01 → 2025-12-31StandaloneOperating income
Operating income¥1.4bn2024-01-01 → 2024-12-31StandaloneOperating income
Ordinary income¥1.4bn2025-01-01 → 2025-12-31StandaloneOrdinary income
Ordinary income¥2.1bn2024-01-01 → 2024-12-31StandaloneOrdinary income
Ordinary income¥1.1bn2023-01-01 → 2023-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥356m2022-01-01 → 2022-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥827m2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥2.2bn2025-01-01 → 2025-12-31StandaloneIncome before income taxes
Profit before tax¥2.4bn2024-01-01 → 2024-12-31StandaloneIncome before income taxes
Net income¥2.3bn2025-01-01 → 2025-12-31StandaloneProfit loss
Net income¥1.8bn2024-01-01 → 2024-12-31StandaloneProfit loss
Net income¥709m2023-01-01 → 2023-12-31dStandaloneNet income loss (5-year summary)
Net income¥1.3bn2022-01-01 → 2022-12-31dStandaloneNet income loss (5-year summary)
Net income¥565m2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Total assets¥40.7bnat 2025-12-31StandaloneAssets
Total assets¥36.0bnat 2024-12-31StandaloneAssets
Total assets¥29.2bnat 2023-12-31dStandaloneTotal assets (5-year summary)
Total assets¥22.3bnat 2022-12-31dStandaloneTotal assets (5-year summary)
Total assets¥23.5bnat 2021-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥21.3bnat 2025-12-31StandaloneLiabilities
Total liabilities¥19.2bnat 2024-12-31StandaloneLiabilities
Net assets / equity¥19.4bnat 2025-12-31StandaloneNet assets
Net assets / equity¥16.9bnat 2024-12-31StandaloneNet assets
Net assets / equity¥10.0bnat 2023-12-31dStandaloneNet assets
Net assets / equity¥9.3bnat 2022-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥7.9bnat 2021-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥4.7bnat 2025-12-31StandaloneCash and deposits
Cash and deposits¥6.7bnat 2024-12-31StandaloneCash and deposits
EPS (basic)¥63.872025-01-01 → 2025-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥58.562024-01-01 → 2024-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥23.722023-01-01 → 2023-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥42.242022-01-01 → 2022-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥18.912021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥62.792025-01-01 → 2025-12-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥57.42024-01-01 → 2024-12-31StandaloneDiluted earnings per share (5-year summary)
Net assets per share¥541.59at 2025-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥477.26at 2024-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥333.28at 2023-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥310.1at 2022-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥265.41at 2021-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio47.5%at 2025-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio46.8%at 2024-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio34.2%at 2023-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio41.6%at 2022-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio33.7%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE12.5%2025-01-01 → 2025-12-31StandaloneRate of return on equity (5-year summary)
ROE13.7%2024-01-01 → 2024-12-31StandaloneRate of return on equity (5-year summary)
ROE7.4%2023-01-01 → 2023-12-31dStandaloneRate of return on equity (5-year summary)
ROE14.7%2022-01-01 → 2022-12-31dStandaloneRate of return on equity (5-year summary)
ROE7.4%2021-01-01 → 2021-12-31dStandaloneRate of return on equity (5-year summary)
Shares issued37,982,900at 2025-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued37,982,900at 2024-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued85,100at 2023-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued85,100at 2022-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued85,100at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees198at 2025-12-31StandaloneNumber of employees
Employees167at 2024-12-31StandaloneNumber of employees
Employees130at 2023-12-31dStandaloneNumber of employees
Employees117at 2022-12-31dStandaloneNumber of employees
Employees119at 2021-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 70
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsdepreciation2025-01-01 → 2025-12-31¥2m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsemployeesat 2025-12-318 pure
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2025-01-01 → 2025-12-31¥656m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2025-01-01 → 2025-12-31¥656m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-01-01 → 2025-12-31¥239m
Reconciling Itemsreconcilingrevenue2025-01-01 → 2025-12-31−¥6m
Reconciling Itemsreconcilingrevenue intersegment2025-01-01 → 2025-12-31−¥6m
Reconciling Itemsreconcilingsegment profit2025-01-01 → 2025-12-31−¥1.4bn
Comprehensive Medical Management Support Businessreportable segmentdepreciation2025-01-01 → 2025-12-31¥386m
Comprehensive Medical Management Support Businessreportable segmentemployeesat 2025-12-31319 pure
Comprehensive Medical Management Support Businessreportable segmentrevenue2025-01-01 → 2025-12-31¥7.7bn
Comprehensive Medical Management Support Businessreportable segmentrevenue external2025-01-01 → 2025-12-31¥7.7bn
Comprehensive Medical Management Support Businessreportable segmentrevenue intersegment2025-01-01 → 2025-12-31¥6m
Comprehensive Medical Management Support Businessreportable segmentsegment profit2025-01-01 → 2025-12-31¥2.4bn
Elderly Care Related Businessreportable segmentdepreciation2025-01-01 → 2025-12-31¥541m
Elderly Care Related Businessreportable segmentemployeesat 2025-12-31910 pure
Elderly Care Related Businessreportable segmentrevenue2025-01-01 → 2025-12-31¥8.9bn
Elderly Care Related Businessreportable segmentrevenue external2025-01-01 → 2025-12-31¥8.9bn
Elderly Care Related Businessreportable segmentsegment profit2025-01-01 → 2025-12-31¥530m
Specially Controlled Medical Device Businessreportable segmentdepreciation2025-01-01 → 2025-12-31¥36m
Specially Controlled Medical Device Businessreportable segmentemployeesat 2025-12-3160 pure
Specially Controlled Medical Device Businessreportable segmentrevenue2025-01-01 → 2025-12-31¥7.5bn
Specially Controlled Medical Device Businessreportable segmentrevenue external2025-01-01 → 2025-12-31¥7.5bn
Specially Controlled Medical Device Businessreportable segmentsegment profit2025-01-01 → 2025-12-31¥525m
—segment totaldepreciation2025-01-01 → 2025-12-31¥963m
—segment totalemployeesat 2025-12-311289 pure
—segment totalrevenue2025-01-01 → 2025-12-31¥24.1bn
—segment totalrevenue external2025-01-01 → 2025-12-31¥24.1bn
—segment totalrevenue intersegment2025-01-01 → 2025-12-31¥6m
—segment totalsegment profit2025-01-01 → 2025-12-31¥3.5bn
Total Of Reportable Segments And Otherssegment totaldepreciation2025-01-01 → 2025-12-31¥965m
Total Of Reportable Segments And Otherssegment totalrevenue2025-01-01 → 2025-12-31¥24.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2025-01-01 → 2025-12-31¥24.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2025-01-01 → 2025-12-31¥6m
Total Of Reportable Segments And Otherssegment totalsegment profit2025-01-01 → 2025-12-31¥3.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsdepreciation2024-01-01 → 2024-12-31¥380,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-01-01 → 2024-12-31¥63m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-01-01 → 2024-12-31¥63m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-01-01 → 2024-12-31−¥140m
Reconciling Itemsreconcilingdepreciation2024-01-01 → 2024-12-31¥70m
Reconciling Itemsreconcilingrevenue2024-01-01 → 2024-12-31−¥9m
Reconciling Itemsreconcilingrevenue intersegment2024-01-01 → 2024-12-31−¥9m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-12-31−¥1.2bn
Comprehensive Medical Management Support Businessreportable segmentdepreciation2024-01-01 → 2024-12-31¥309m
Comprehensive Medical Management Support Businessreportable segmentrevenue2024-01-01 → 2024-12-31¥6.4bn
Comprehensive Medical Management Support Businessreportable segmentrevenue external2024-01-01 → 2024-12-31¥6.4bn
Comprehensive Medical Management Support Businessreportable segmentrevenue intersegment2024-01-01 → 2024-12-31¥9m
Comprehensive Medical Management Support Businessreportable segmentsegment profit2024-01-01 → 2024-12-31¥2.8bn
Elderly Care Related Businessreportable segmentdepreciation2024-01-01 → 2024-12-31¥514m
Elderly Care Related Businessreportable segmentrevenue2024-01-01 → 2024-12-31¥6.9bn
Elderly Care Related Businessreportable segmentrevenue external2024-01-01 → 2024-12-31¥6.9bn
Elderly Care Related Businessreportable segmentsegment profit2024-01-01 → 2024-12-31¥309m
Specially Controlled Medical Device Businessreportable segmentdepreciation2024-01-01 → 2024-12-31¥33m
Specially Controlled Medical Device Businessreportable segmentrevenue2024-01-01 → 2024-12-31¥6.5bn
Specially Controlled Medical Device Businessreportable segmentrevenue external2024-01-01 → 2024-12-31¥6.5bn
Specially Controlled Medical Device Businessreportable segmentsegment profit2024-01-01 → 2024-12-31¥485m
—segment totaldepreciation2024-01-01 → 2024-12-31¥857m
—segment totalrevenue2024-01-01 → 2024-12-31¥19.8bn
—segment totalrevenue external2024-01-01 → 2024-12-31¥19.8bn
—segment totalrevenue intersegment2024-01-01 → 2024-12-31¥9m
—segment totalsegment profit2024-01-01 → 2024-12-31¥3.6bn
Total Of Reportable Segments And Otherssegment totaldepreciation2024-01-01 → 2024-12-31¥857m
Total Of Reportable Segments And Otherssegment totalrevenue2024-01-01 → 2024-12-31¥19.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-01-01 → 2024-12-31¥19.8bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-01-01 → 2024-12-31¥9m
Total Of Reportable Segments And Otherssegment totalsegment profit2024-01-01 → 2024-12-31¥3.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsemployeesat 2025-12-318 pure
Comprehensive Medical Management Support Businessreportable segmentemployeesat 2025-12-31134 pure
Elderly Care Related Businessreportable segmentemployeesat 2025-12-316 pure
—segment totalemployeesat 2025-12-31140 pure

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,719
ItemContextValueUnit
Goodwill before offsettingPrior1YearInstant_jpcrp030000-asr_E12328-000ElderlyCareRelatedBusinessReportableSegmentMember425514000JPY
Goodwill before offsettingPrior1YearInstant_jpcrp030000-asr_E12328-000SpeciallyControlledMedicalDeviceBusinessReportableSegmentMember416131000JPY
Goodwill before offsettingPrior1YearInstant_ReportableSegmentsMember841646000JPY
Goodwill before offsettingPrior1YearInstant_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Goodwill before offsettingPrior1YearInstant_TotalOfReportableSegmentsAndOthersMember841646000JPY
Goodwill before offsettingPrior1YearInstant_ReconcilingItemsMember－JPY
Goodwill before offsettingPrior1YearInstant841646000JPY
Goodwill before offsettingCurrentYearInstant_jpcrp030000-asr_E12328-000ComprehensiveMedicalManagementSupportBusinessReportableSegmentMember1192267000JPY
Goodwill before offsettingCurrentYearInstant_jpcrp030000-asr_E12328-000ElderlyCareRelatedBusinessReportableSegmentMember784927000JPY
Goodwill before offsettingCurrentYearInstant_jpcrp030000-asr_E12328-000SpeciallyControlledMedicalDeviceBusinessReportableSegmentMember369401000JPY
Goodwill before offsettingCurrentYearInstant_ReportableSegmentsMember2346596000JPY
Goodwill before offsettingCurrentYearInstant_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember－JPY
Goodwill before offsettingCurrentYearInstant_TotalOfReportableSegmentsAndOthersMember2346596000JPY
Goodwill before offsettingCurrentYearInstant_ReconcilingItemsMember－JPY
Goodwill before offsettingCurrentYearInstant2346596000JPY
Cash and depositsPrior1YearInstant_NonConsolidatedMember6693881000JPY
Cash and depositsCurrentYearInstant_NonConsolidatedMember4724691000JPY
Accounts receivable tradePrior1YearInstant_NonConsolidatedMember1706129000JPY
Accounts receivable tradeCurrentYearInstant_NonConsolidatedMember2235267000JPY
Short term investment securitiesPrior1YearInstant_NonConsolidatedMember－JPY
Short term investment securitiesCurrentYearInstant_NonConsolidatedMember200000000JPY
Work in processPrior1YearInstant_NonConsolidatedMember12625000JPY
Work in processCurrentYearInstant_NonConsolidatedMember13786000JPY
Raw materials and suppliesPrior1YearInstant_NonConsolidatedMember241822000JPY
Raw materials and suppliesCurrentYearInstant_NonConsolidatedMember228927000JPY
Real estate for salePrior1YearInstant_NonConsolidatedMember－JPY
Real estate for saleCurrentYearInstant_NonConsolidatedMember634954000JPY
Prepaid expensesPrior1YearInstant_NonConsolidatedMember123841000JPY
Prepaid expensesCurrentYearInstant_NonConsolidatedMember213129000JPY
Short term loans receivablePrior1YearInstant_NonConsolidatedMember1232000000JPY
Short term loans receivableCurrentYearInstant_NonConsolidatedMember3095200000JPY
Operating loans caPrior1YearInstant_NonConsolidatedMember1879927000JPY
Operating loans caCurrentYearInstant_NonConsolidatedMember2526502000JPY
Lease investment assets caPrior1YearInstant_NonConsolidatedMember4168384000JPY
Lease investment assets caCurrentYearInstant_NonConsolidatedMember4125172000JPY
Other caPrior1YearInstant_NonConsolidatedMember41271000JPY
Other caCurrentYearInstant_NonConsolidatedMember518493000JPY
Current assetsPrior1YearInstant_NonConsolidatedMember16099883000JPY
Current assetsCurrentYearInstant_NonConsolidatedMember18516124000JPY
BuildingsPrior1YearInstant_NonConsolidatedMember7306271000JPY
BuildingsCurrentYearInstant_NonConsolidatedMember7369578000JPY
Accumulated depreciation buildingsPrior1YearInstant_NonConsolidatedMember-1984650000JPY
Accumulated depreciation buildingsCurrentYearInstant_NonConsolidatedMember-2182019000JPY
Buildings netPrior1YearInstant_NonConsolidatedMember5321620000JPY
Buildings netCurrentYearInstant_NonConsolidatedMember5187559000JPY
StructuresPrior1YearInstant_NonConsolidatedMember100728000JPY
StructuresCurrentYearInstant_NonConsolidatedMember187513000JPY
Accumulated depreciation structuresPrior1YearInstant_NonConsolidatedMember-45227000JPY
Accumulated depreciation structuresCurrentYearInstant_NonConsolidatedMember-57635000JPY
Structures netPrior1YearInstant_NonConsolidatedMember55500000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 24 of 24 passed
balance sheet identityconsolidated 2024-12-31pass
balance sheet identityconsolidated 2025-12-31pass
balance sheet identitynon_consolidated 2024-12-31pass rounding
balance sheet identitynon_consolidated 2025-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net assetsconsolidated 2024-12-31pass
statement vs summary · net assetsconsolidated 2025-12-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2024-12-31pass
statement vs summary · net assetsnon_consolidated 2025-12-31pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-12-31pass
statement vs summary · net income attributable to parentconsolidated 2025-01-01/2025-12-31pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-12-31pass
statement vs summary · operating cash flowconsolidated 2025-01-01/2025-12-31pass
statement vs summary · revenueconsolidated 2024-01-01/2024-12-31pass
statement vs summary · revenueconsolidated 2025-01-01/2025-12-31pass
statement vs summary · revenuenon_consolidated 2024-01-01/2024-12-31pass
statement vs summary · revenuenon_consolidated 2025-01-01/2025-12-31pass
statement vs summary · total assetsconsolidated 2024-12-31pass
statement vs summary · total assetsconsolidated 2025-12-31pass
statement vs summary · total assetsnon_consolidated 2024-12-31pass
statement vs summary · total assetsnon_consolidated 2025-12-31pass